89 related articles for article (PubMed ID: 22585854)
1. Regulating the TRAIL of destruction: how A20 protects glioblastomas from TRAIL-mediated death.
Verbrugge I; Johnstone RW
Cancer Discov; 2012 Feb; 2(2):112-4. PubMed ID: 22585854
[TBL] [Abstract][Full Text] [Related]
2. A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma.
Bellail AC; Olson JJ; Yang X; Chen ZJ; Hao C
Cancer Discov; 2012 Feb; 2(2):140-55. PubMed ID: 22585859
[TBL] [Abstract][Full Text] [Related]
3. miR-200a enhances TRAIL-induced apoptosis in gastric cancer cells by targeting A20.
Guo T; Zhang Y; Qu X; Che X; Li C; Fan Y; Wan X; Ma R; Hou K; Zhou H; He X; Hu X; Liu Y; Xu L
Cell Biol Int; 2018 May; 42(5):506-514. PubMed ID: 29274253
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B Virus X Protein Sensitizes TRAIL-Induced Hepatocyte Apoptosis by Inhibiting the E3 Ubiquitin Ligase A20.
Zhang H; Huang C; Wang Y; Lu Z; Zhuang N; Zhao D; He J; Shi L
PLoS One; 2015; 10(5):e0127329. PubMed ID: 25993287
[TBL] [Abstract][Full Text] [Related]
5. Targeting A20 enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells.
Dong B; Lv G; Wang Q; Wei F; Bellail AC; Hao C; Wang G
Biochem Biophys Res Commun; 2012 Feb; 418(2):433-8. PubMed ID: 22285182
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel pro-apoptotic role of NF-κB in the regulation of TRAIL- and CD95-mediated apoptosis of glioblastoma cells.
Jennewein C; Karl S; Baumann B; Micheau O; Debatin KM; Fulda S
Oncogene; 2012 Mar; 31(11):1468-74. PubMed ID: 21822306
[TBL] [Abstract][Full Text] [Related]
7. The seventh zinc finger motif of A20 is required for the suppression of TNF-α-induced apoptosis.
Yamaguchi N; Yamaguchi N
FEBS Lett; 2015 May; 589(12):1369-75. PubMed ID: 25911380
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction.
Eramo A; Pallini R; Lotti F; Sette G; Patti M; Bartucci M; Ricci-Vitiani L; Signore M; Stassi G; Larocca LM; Crinò L; Peschle C; De Maria R
Cancer Res; 2005 Dec; 65(24):11469-77. PubMed ID: 16357155
[TBL] [Abstract][Full Text] [Related]
9. Catalytically active Yersinia outer protein P induces cleavage of RIP and caspase-8 at the level of the DISC independently of death receptors in dendritic cells.
Gröbner S; Adkins I; Schulz S; Richter K; Borgmann S; Wesselborg S; Ruckdeschel K; Micheau O; Autenrieth IB
Apoptosis; 2007 Oct; 12(10):1813-25. PubMed ID: 17624595
[TBL] [Abstract][Full Text] [Related]
10. Itching to end NF-kappaB.
Heissmeyer V; Rao A
Nat Immunol; 2008 Mar; 9(3):227-9. PubMed ID: 18285770
[No Abstract] [Full Text] [Related]
11. RIP1 has a role in CD40-mediated apoptosis in human follicular lymphoma cells.
Adem J; Eray M; Eeva J; Nuutinen U; Pelkonen J
Immunobiology; 2017 Nov; 222(11):998-1003. PubMed ID: 28610909
[TBL] [Abstract][Full Text] [Related]
12. DR5-Cbl-b/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells.
Xu L; Zhang Y; Qu X; Che X; Guo T; Li C; Ma R; Fan Y; Ma Y; Hou K; Li D; Hu X; Liu B; Yu R; Yan H; Gong J; Liu Y
Mol Oncol; 2017 Dec; 11(12):1733-1751. PubMed ID: 28972304
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of RIP and c-FLIP in preventing liver cancer cell apoptosis induced by TRAIL.
Sun J; Luo H; Nie W; Xu X; Miao X; Huang F; Wu H; Jin X
Int J Clin Exp Pathol; 2015; 8(6):6519-25. PubMed ID: 26261530
[TBL] [Abstract][Full Text] [Related]
14. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA
Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625
[TBL] [Abstract][Full Text] [Related]
15. TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.
Zhang L; Dittmer MR; Blackwell K; Workman LM; Hostager B; Habelhah H
Cell Signal; 2015 Feb; 27(2):306-14. PubMed ID: 25446254
[TBL] [Abstract][Full Text] [Related]
16. Possible role of death receptor-mediated apoptosis by the E3 ubiquitin ligases Siah2 and POSH.
Christian PA; Fiandalo MV; Schwarze SR
Mol Cancer; 2011 May; 10():57. PubMed ID: 21586138
[TBL] [Abstract][Full Text] [Related]
17. RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex.
Abhari BA; Cristofanon S; Kappler R; von Schweinitz D; Humphreys R; Fulda S
Oncogene; 2013 Jul; 32(27):3263-73. PubMed ID: 22890322
[TBL] [Abstract][Full Text] [Related]
18. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.
Wertz IE; O'Rourke KM; Zhou H; Eby M; Aravind L; Seshagiri S; Wu P; Wiesmann C; Baker R; Boone DL; Ma A; Koonin EV; Dixit VM
Nature; 2004 Aug; 430(7000):694-9. PubMed ID: 15258597
[TBL] [Abstract][Full Text] [Related]
19. Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8.
Shin S; Lee Y; Kim W; Ko H; Choi H; Kim K
EMBO J; 2005 Oct; 24(20):3532-42. PubMed ID: 16193064
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP.
Bangert A; Cristofanon S; Eckhardt I; Abhari BA; Kolodziej S; Häcker S; Vellanki SH; Lausen J; Debatin KM; Fulda S
Oncogene; 2012 Nov; 31(44):4677-88. PubMed ID: 22266862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]